23,071 Shares in SiriusPoint Ltd. $SPNT Acquired by Legato Capital Management LLC

Legato Capital Management LLC purchased a new position in shares of SiriusPoint Ltd. (NYSE:SPNT) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 23,071 shares of the company’s stock, valued at approximately $505,000.

Several other institutional investors have also made changes to their positions in the stock. Leonteq Securities AG acquired a new stake in shares of SiriusPoint during the fourth quarter worth approximately $136,000. ProShare Advisors LLC boosted its holdings in shares of SiriusPoint by 3.2% during the fourth quarter. ProShare Advisors LLC now owns 19,954 shares of the company’s stock worth $437,000 after purchasing an additional 612 shares during the period. Swiss Life Asset Management Ltd acquired a new stake in shares of SiriusPoint during the fourth quarter worth approximately $269,000. Sequoia Financial Advisors LLC lifted its stake in SiriusPoint by 5.4% in the fourth quarter. Sequoia Financial Advisors LLC now owns 16,994 shares of the company’s stock valued at $372,000 after acquiring an additional 873 shares during the last quarter. Finally, Horizon Investments LLC acquired a new stake in SiriusPoint in the fourth quarter valued at approximately $1,296,000. 52.79% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on SPNT shares. Weiss Ratings lowered shares of SiriusPoint from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Monday, May 11th. Wall Street Zen lowered shares of SiriusPoint from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. B. Riley Financial began coverage on shares of SiriusPoint in a research report on Friday, April 17th. They set a “buy” rating and a $31.00 target price on the stock. Jefferies Financial Group raised shares of SiriusPoint to a “hold” rating in a research report on Wednesday, February 4th. Finally, Zacks Research lowered shares of SiriusPoint from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $28.00.

SiriusPoint Trading Down 1.1%

Shares of SPNT stock opened at $23.07 on Wednesday. The firm has a market capitalization of $2.71 billion, a P/E ratio of 5.74 and a beta of 0.66. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.30. The firm’s fifty day simple moving average is $22.57 and its 200 day simple moving average is $21.45. SiriusPoint Ltd. has a 1 year low of $17.17 and a 1 year high of $24.32.

SiriusPoint (NYSE:SPNT) last announced its quarterly earnings results on Tuesday, March 31st. The company reported $0.70 earnings per share (EPS) for the quarter. The firm had revenue of $774.60 million for the quarter. SiriusPoint had a net margin of 15.38% and a return on equity of 16.92%. As a group, sell-side analysts predict that SiriusPoint Ltd. will post 2.56 EPS for the current year.

SiriusPoint Company Profile

SiriusPoint Ltd. is a global insurance and reinsurance company headquartered in Bermuda, offering a broad range of property and casualty solutions to clients around the world. The company operates through two core segments: reinsurance, which provides treaty and facultative coverage across property, casualty and specialty lines; and insurance, which underwrites specialty programs, fronting arrangements and other tailored products for commercial and niche markets. This integrated model allows SiriusPoint to leverage shared underwriting expertise and capital efficiency across its product suite.

On the reinsurance side, SiriusPoint’s offerings include coverage for natural catastrophes, casualty losses, political risk and other complex exposures, with both proportional and non-proportional treaty structures.